1-10 of 10
Kelly Valla
Close
Sort by
Journal Articles

Bendamustine, Obinutuzumab and Venetoclax Results in High Complete Response Rates in Untreated Mantle Cell Lymphoma

Irl Brian Greenwell, Jeffrey M. Switchenko, Alexander F.M. Craig, Ash A. Alizadeh, Pamela B. Allen, Alicia Escobar, Kelly Valla, Aseala Abousaud, Priya Parikh, Danielle Roberts, Jessica J. Neely, Alexandra Palmer, Kristie A. Blum, Jonathon B. Cohen, Marcela Algave
Journal: Blood
Blood (2022) 140 (Supplement 1): 9373–9374.
https://doi.org/10.1182/blood-2022-167947
Published: 2022
Journal Articles

Discontinuation Due to Toxicity Limits Treatment Duration of BTK Inhibitors in Non-Hodgkin Lymphoma

Drew G Gerber, Yichun Cao, Jeffrey M. Switchenko, Kelly Valla, Jonathon B. Cohen
Journal: Blood
Blood (2021) 138 (Supplement 1): 4685.
https://doi.org/10.1182/blood-2021-151791
Published: 2021
Journal Articles

Bendamustine, Obinutuzumab and Venetoclax As Induction Therapy for Untreated Mantle Cell Lymphoma

Irl Brian Greenwell, MD, Jeffrey M. Switchenko, PhD MS, Kami J. Maddocks, MD, Brad S. Kahl, MD, Alexander F. M. Craig, MPhil, Ash A. Alizadeh, MD PhD, Pamela B. Allen, MD MSc, Alena Lorretta Marbury, BS, Alicia Escobar, Kelly Valla, PharmD, Miayea Williams, Priya Parikh, Danielle Roberts, PA-C, Jessica J. Neely, PA-C, Alexandra Palmer, NP-C, Kristie A. Blum, MD, Jonathon B. Cohen, MDMS
Journal: Blood
Blood (2020) 136 (Supplement 1): 33–34.
https://doi.org/10.1182/blood-2020-141454
Published: 2020
Journal Articles

Ixazomib with or without Rituximab Following Immunochemotherapy and Autologous Stem Cell Transplant in Mantle Cell Lymphoma

Jason T. Romancik, MD, Pamela B. Allen, MD MSc, Edmund K. Waller, PhDMD, Zhengjia Chen, PhD, Kelly Valla, PharmD, Kaylan Dixon, BS, David J. Reagan, Amanda B. Colbert, Cecilia Rosand, PA-C, Alexandra Palmer, NP-C, Christopher Flowers, MDMS, Jonathon B. Cohen, MDMS
Journal: Blood
Blood (2020) 136 (Supplement 1): 39.
https://doi.org/10.1182/blood-2020-141030
Published: 2020
Journal Articles

Pentotstatin/TBI Conditioning Is Well-Tolerated and Permits Engraftment of a Second Allogeneic Stem Cell Transplant Following Primary or Secondary Rejection of an Allogeneic Hematopoietic Stem Graft

Ani Gvajaia, MD, Amelia Langston, MD, Natia Esiashvil, MD, Michael Graiser, PhD, Kelly Valla, PharmD, Edmund K. Waller, PhDMD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5657.
https://doi.org/10.1182/blood-2019-122467
Published: 2019
Journal Articles

Intrathecal Central Nervous System Prophylaxis in Patients with Diffuse Large B-Cell Lymphoma at an Academic Healthcare System

Kevin H. Hall, PharmD, Kelly Valla, PharmD, BCOP, Jonathon B Cohen, MDMS, Christopher Flowers, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4155.
https://doi.org/10.1182/blood.V130.Suppl_1.4155.4155
Published: 2017
Journal Articles

Initial Salvage Approaches for Relapsed/Refractory Mantle Cell Lymphoma Have Comparable Response Rates, Progression-Free and Overall Survival

Sarah Caulfield, PharmD, Danielle Schlafer, Pharm D, BCOP, Jeffrey M. Switchenko, PhD MS, Irl Brian Greenwell, MD, Ashley D. Staton, MD, Kristie A. Blum, MD, Natalie Grover, MD, Steven I Park, MD, Alexey Danilov, MD PhD, Narendranath Epperla, MD, Timothy S. Fenske, MD, Mehdi Hamadani, MD, Max J Gordon, MD, Stephanie Mathews, Kelly Valla, PharmD, BCOP, Christopher Flowers, MD, Jonathon B Cohen, MDMS
Journal: Blood
Blood (2017) 130 (Supplement 1): 1505.
https://doi.org/10.1182/blood.V130.Suppl_1.1505.1505
Published: 2017
Journal Articles

Vorinostat, Bortezomib, Cyclophosphomide, Thalidomide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients

Charise Gleason, MSN, ANP-BC, AOCNP, Jonathan L. Kaufman, MD, Ajay K. Nooka, MD MPH, Kelly Valla, PharmD, BCOP, Leonard T Heffner, MD, Aditya Singh Bisht, Sanjay Manubolu, Melanie Watson, Lawrence H. Boise, PhD, Sagar Lonial, MD
Journal: Blood
Blood (2014) 124 (21): 5773.
https://doi.org/10.1182/blood.V124.21.5773.5773
Published: 2014
Journal Articles

Colesevelam Hydrochloride for the Treatment of Lenalidomide Induced Diarrhea

Melanie Watson, RN, OCN, Ajay K. Nooka, MD MPH, Charise Gleason, MSN, ANP-BC, AOCNP, Kelly Valla, PharmD, BCOP, Jonathan L. Kaufman, MD, Sagar Lonial, MD
Journal: Blood
Blood (2014) 124 (21): 5779.
https://doi.org/10.1182/blood.V124.21.5779.5779
Published: 2014
Journal Articles

Bortezomib in Combination with Dexamethasone, Cyclophosphamide, Etoposide, and Cisplatin (V-DCEP) for the Treatment of Multiple Myeloma

Kelly Valla, PharmD, BCOP, Jonathan L. Kaufman, MD, Charise Gleason, MSN, ANP-BC, AOCNP, Lawrence H. Boise, PhD, Leonard T Heffner, MD, Sanjay Manubolu, Aditya Singh Bisht, Melanie Watson, Ajay K. Nooka, MD MPH, Sagar Lonial, MD
Journal: Blood
Blood (2014) 124 (21): 2139.
https://doi.org/10.1182/blood.V124.21.2139.2139
Published: 2014